| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.08 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.08 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.08 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.08 |